-
-
On July 4, 2008, in one of the more tragic medical accidents in recent memory, 14 babies in the ICU at Christus Spohn Hospital South in Corpus Christi, TX, received doses of Heparin that were 100 times stronger than the recommended doses, according to the Associated Press (AP). Two of the babies died, reported the AP, which also said the hospital blamed a "mixing error" in the pharmacy.
-
The Joint Commission, continuing a trend among leading health care quality organizations, has placed an emphasis on hospital-acquired infections, or HAIs, in its National Patient Safety Goals for 2009.
-
-
The FDA's amended rule for acceptance of foreign clinical studies not conducted under an investigational new drug (IND) application has drawn fire from health advocates who say it weakens ethical protections.
-
Ethicists and others continue to find it troubling that payments to research participants are part of the recruitment process.
-
From a bioethical perspective, payments to research participants are complicated, an expert says.
-
Every study participant has seen some variation of this assurance in informed consent documents: "You are free to participate in this research or to withdraw at any time without penalty or loss of benefits you are entitled to receive."
-
-
Two or more IRBs reviewing the same study might reach strikingly different conclusions about the study's risks and suitability for human subjects.